BONE ABSORPTIOMETRY IN METABOLIC BONE-DISEASE - BASE-LINE VALUES AND LONG-TERM TREATMENT WITH CALCITRIOL (POSTMENOPAUSAL OSTEOPOROSIS VERSUS OSTEOMALACIA)
A. Caniggia et B. Frediani, BONE ABSORPTIOMETRY IN METABOLIC BONE-DISEASE - BASE-LINE VALUES AND LONG-TERM TREATMENT WITH CALCITRIOL (POSTMENOPAUSAL OSTEOPOROSIS VERSUS OSTEOMALACIA), Cells and materials, 5(2), 1995, pp. 139-148
Citations number
37
Categorie Soggetti
Cell Biology","Medicine, Research & Experimental","Materials Science, Biomaterials
Total body bone absorptiometry reveals low mineral density in both pos
tmenopausal osteoporosis and osteomalacia patients. The method was use
d to investigate the effect of calcitriol administration on patients s
uffering from one of these conditions. In osteomalacia, the administra
tion of calcitriol resulted in a dramatic improvement in bone mineral
density (sometimes up to 50% in 12 months), indicating the rapid miner
alization of previously uncalcified bone tissue as a result of the nor
malization of the Ca x P product. In osteoporosis a similar treatment
was seen to halt the progressive decrease in bone mineral levels and s
ometimes resulted in minor increases in density (up to 5%). This is li
kely to be due to a normalization of intestinal calcium malabsorption
which halts secondary homeostatic bone resorption.